Earned-first value Havas SO emphasizes an earned-first foundation across PR, social, patient engagement, and health communications, suggesting opportunities to upsell integrated earned media strategies and credibility-driven campaigns for health brands seeking impact with skeptical audiences.

Health sector focus Specialization at the intersection of culture, science, and storytelling with a healthcare emphasis signals sales potential with pharmaceutical, biotech, and patient advocacy clients seeking evidence-based, empathetic engagement and measurable real-world outcomes.

AI driven insights The use of AI-powered insight alongside collective intelligence presents an entry point for selling advanced analytics, audience segmentation, and performance optimization services to improve campaign effectiveness and efficiency.

Mid-market niche With 51-200 employees and revenue in the low millions, Havas SO sits in the mid-market, offering upsell opportunities for larger health and pharma players seeking scalable, integrated PR and health comms capabilities without engaging bigger firms.

Digital and creative stack Tech stack including Google Ads, Adobe Creative Cloud, Figma, Squarespace, and OneTrust indicates potential for cross-sell of digital advertising, content production, brand experiences, compliance-ready marketing, and workflow tools to streamline client campaigns.